agilon health (NYSE:AGL) Coverage Initiated at Sanford C. Bernstein

Equities research analysts at Sanford C. Bernstein began coverage on shares of agilon health (NYSE:AGL) in a research report issued on Wednesday, Marketbeat Ratings reports. The brokerage set a “market perform” rating and a $2.50 price target on the stock. Sanford C. Bernstein’s price objective indicates a potential upside of 12.11% from the company’s previous close.

A number of other equities analysts also recently commented on the stock. Stifel Nicolaus lowered their target price on shares of agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a research note on Tuesday, November 12th. Citigroup dropped their price objective on agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a report on Wednesday, November 13th. JMP Securities cut agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Barclays dropped their price target on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research note on Monday, November 11th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $3.00 price objective on shares of agilon health in a research report on Tuesday, November 19th. Three analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $4.38.

agilon health Stock Performance

Shares of AGL stock opened at $2.23 on Wednesday. The firm has a 50 day moving average of $2.46 and a two-hundred day moving average of $4.42. The stock has a market capitalization of $918.80 million, a PE ratio of -2.37 and a beta of 0.51. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a 52 week low of $1.50 and a 52 week high of $13.76.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The company had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.47 billion. During the same quarter last year, the company earned ($0.06) EPS. On average, research analysts predict that agilon health will post -0.5 EPS for the current fiscal year.

Insider Activity at agilon health

In other news, Director John William Wulf bought 45,000 shares of agilon health stock in a transaction dated Thursday, December 5th. The stock was bought at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the purchase, the director now owns 206,133 shares of the company’s stock, valued at approximately $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Diana Mckenzie purchased 12,500 shares of the company’s stock in a transaction dated Monday, November 25th. The shares were purchased at an average price of $2.28 per share, for a total transaction of $28,500.00. Following the completion of the purchase, the director now owns 51,319 shares of the company’s stock, valued at approximately $117,007.32. This trade represents a 32.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 65,000 shares of company stock worth $143,100 in the last quarter. Company insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

A number of hedge funds have recently added to or reduced their stakes in the company. AQR Capital Management LLC raised its stake in shares of agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after buying an additional 1,316,990 shares in the last quarter. Susquehanna Fundamental Investments LLC raised its position in agilon health by 65.0% in the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after acquiring an additional 316,856 shares in the last quarter. Citigroup Inc. lifted its holdings in agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after acquiring an additional 1,941,993 shares during the period. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in agilon health in the second quarter valued at $1,849,000. Finally, Neo Ivy Capital Management purchased a new stake in shares of agilon health during the 2nd quarter worth $1,006,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.